Solana Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 30-07-2024
- Paid Up Capital ₹ 3.53 Cr
as on 30-07-2024
- Company Age 25 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.65 Cr
as on 30-07-2024
- Satisfied Charges ₹ 11.61 Cr
as on 30-07-2024
- Revenue -12.15%
(FY 2023)
- Profit 137.25%
(FY 2023)
- Ebitda 11.46%
(FY 2023)
- Net Worth 16.32%
(FY 2023)
- Total Assets 42.32%
(FY 2023)
About Solana Life Sciences
The Corporate was formerly known as Panakeia Drugs And Intermediates Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.53 Cr.
The company currently has active open charges totaling ₹19.65 Cr. The company has closed loans amounting to ₹11.61 Cr, as per Ministry of Corporate Affairs (MCA) records.
Yash Joshi and Arun Joshi serve as directors at the Company.
- CIN/LLPIN
U24231MP1999PTC013742
- Company No.
013742
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Dhar, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Solana Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yash Joshi  | Director | 26-Jun-2019 | Current |
| Arun Joshi | Director | 26-Jun-2019 | Current |
Financial Performance of Solana Life Sciences.
Solana Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.15% decrease. The company also saw a substantial improvement in profitability, with a 137.25% increase in profit. The company's net worth Soared by an impressive increase of 16.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Solana Life Sciences?
In 2023, Solana Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ankleshwar Research And Analytical Infrastructure AssociationActive 19 years 7 monthsArun Joshi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 19 Oct 2022 | ₹5.62 Cr | Open |
Axis Bank Limited Creation Date: 29 Sep 2022 | ₹5.62 Cr | Open |
Axis Bank Limited Creation Date: 30 Jul 2021 | ₹8.41 Cr | Open |
How Many Employees Work at Solana Life Sciences?
Solana Life Sciences has a workforce of 27 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Solana Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solana Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
